Study identifies new PD-1 immune checkpoint mechanism promoting Merkel cell carcinoma growth

Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart